Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
|
To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria |
Severe Malaria | Phase2 |
Burkina Faso Congo, The Democratic Republic of the Côte D'Ivoire Gabon Kenya Mozambique Nigeria Rwanda Uganda View All
|
NCT04675931 |
|
Home Reported Outcomes in PNH |
Paroxysmal Nocturnal Hemoglobinuria | United States | NCT06411626 | |
|
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis |
Diffuse Cutaneous Systemic Sclerosis | Phase2 |
Argentina Austria Belgium Brazil China Colombia France Germany Greece Hungary India Italy Mexico Poland Portugal South Korea Spain Taiwan Thailand Turkey (Türkiye) United Kingdom United States Vietnam View All
|
NCT06470048 |
|
A 24-week rPMS Study in Real-world Setting for Enerzair |
Asthma | South Korea | NCT05274425 | |
|
Migraine Survey in Gulf Region |
Migraine | United Arab Emirates | NCT06237062 | |
|
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa. |
Hidradenitis Suppurativa | Germany | NCT05921994 | |
|
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma |
Asthma | Phase2 |
Bulgaria Colombia Guatemala Hungary Poland South Africa Spain United Kingdom View All
|
NCT05222529 |
|
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy |
Primary IgA Nephropathy | Phase3 |
Argentina Australia Belgium Brazil China Colombia Czechia Denmark France Germany Hong Kong Hungary India Israel Italy Japan Malaysia Mexico Netherlands Singapore Slovenia South Korea Spain Sweden Taiwan Thailand Turkey (Türkiye) United Kingdom United States View All
|
NCT04557462 |
|
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials |
Spinal Muscular Atrophy (SMA) | Phase3 |
Australia Belgium Canada China Denmark France Italy Japan Malaysia Netherlands Saudi Arabia Singapore Spain Taiwan Thailand United Kingdom United States Vietnam View All
|
NCT05335876 |
|
Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies |
B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL) | Phase1 |
Belgium China France Israel Italy Japan Singapore Spain United States View All
|
NCT05397496 |